ClinicalTrials.govpublic full text
Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)
amyotrophic lateral sclerosis, als, histone deacetylase inhibition, open label, safety study, sodium phenylbutyrate, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843573
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.